Last reviewed · How we verify
Collection of blood samples
Collection of blood samples is a Biologic drug developed by University Hospital, Angers. It is currently FDA-approved for Diagnostic testing and laboratory analysis, Clinical research and biobanking.
Blood sample collection is a diagnostic procedure that obtains venous blood specimens for laboratory analysis and testing.
Blood sample collection is a diagnostic procedure that obtains venous blood specimens for laboratory analysis and testing. Used for Diagnostic testing and laboratory analysis, Clinical research and biobanking.
At a glance
| Generic name | Collection of blood samples |
|---|---|
| Sponsor | University Hospital, Angers |
| Modality | Biologic |
| Therapeutic area | Diagnostics |
| Phase | FDA-approved |
Mechanism of action
This is a clinical procedure rather than a pharmaceutical drug. Blood samples are collected from patients to enable laboratory testing for various diagnostic, monitoring, and research purposes. The samples are analyzed to assess patient health status, diagnose conditions, monitor treatment efficacy, and support clinical research.
Approved indications
- Diagnostic testing and laboratory analysis
- Clinical research and biobanking
Common side effects
- Venipuncture site bruising
- Mild discomfort or pain at collection site
- Vasovagal response (dizziness, fainting)
Key clinical trials
- Collection of Blood From Patients With Prostate Cancer
- Screening and Multiple Intervention on Lung Epidemics (PHASE2)
- Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer (PHASE2)
- Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial (PHASE2)
- Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial (PHASE1)
- Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma (PHASE3)
- Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm (PHASE2)
- Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Collection of blood samples CI brief — competitive landscape report
- Collection of blood samples updates RSS · CI watch RSS
- University Hospital, Angers portfolio CI
Frequently asked questions about Collection of blood samples
What is Collection of blood samples?
How does Collection of blood samples work?
What is Collection of blood samples used for?
Who makes Collection of blood samples?
What development phase is Collection of blood samples in?
What are the side effects of Collection of blood samples?
Related
- Manufacturer: University Hospital, Angers — full pipeline
- Therapeutic area: All drugs in Diagnostics
- Indication: Drugs for Diagnostic testing and laboratory analysis
- Indication: Drugs for Clinical research and biobanking
- Compare: Collection of blood samples vs similar drugs
- Pricing: Collection of blood samples cost, discount & access